Vimarsana
Biggest News Aggregation in the World

Page 20 - Device Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Designation Today - Breaking & Trending Today

PRAPELA RECEIVES FDA'S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY - Vimarsana News

PRAPELA RECEIVES FDA'S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY

FDA Breakthrough Device Designations speed up the development and review of medical devices that can improve the lives of people with life-threate...

PRAPELA RECEIVES FDA'S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY - Vimarsana News

PRAPELA RECEIVES FDA'S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY

/PRNewswire/ -- Prapela, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to explore the use of its...

Investegate |Burning Rock Biotech Announcements | Burning Rock Biotech: BNR Received FDA Breakthrough Device Designation - Vimarsana News

Investegate |Burning Rock Biotech Announcements | Burning Rock Biotech: BNR Received FDA Breakthrough Device Designation

Investegate announcements from Burning Rock Biotech, BNR Received FDA Breakthrough Device Designation

Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test - Vimarsana News

Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

/PRNewswire/ -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision...

CytoSorbents: DSMB Recommends To Continue Pivotal STAR-T Trial Without Any Modifications - Vimarsana News

CytoSorbents: DSMB Recommends To Continue Pivotal STAR-T Trial Without Any Modifications

LONDON (dpa-AFX) - CytoSorbents Corp. (CTSO) said Wednesday that it has received the recommendation from the independent Data and Safety Monitoring Board or DSMB to continue the pivotal Safe and